Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Bilateral breast carcinoma: clinical characteristics and its impact on survival.

Vuoto HD, García AM, Candás GB, Zimmermann AG, Uriburu JL, Isetta JA, Cogorno L, Khoury M, Bernabó OL.

Breast J. 2010 Nov-Dec;16(6):625-32. doi: 10.1111/j.1524-4741.2010.00976.x.

PMID:
21070440
2.

Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility study.

Tsoi D, Holloway C, Bordeleau L, Brezden-Masley C, Causer P, Warner E.

Breast. 2011 Feb;20(1):96-8. doi: 10.1016/j.breast.2010.08.006. Epub 2010 Sep 9.

PMID:
20829043
3.

In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience.

Bernard JR Jr, Vallow LA, DePeri ER, McNeil RB, Feigel DG, Amar S, Buskirk SJ, Perez EA.

Breast J. 2010 Mar-Apr;16(2):118-26. doi: 10.1111/j.1524-4741.2009.00890.x. Epub 2010 Jan 29.

PMID:
20136645
4.

Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. Review.

5.

Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening.

Autier P, Héry C, Haukka J, Boniol M, Byrnes G.

J Clin Oncol. 2009 Dec 10;27(35):5919-23. doi: 10.1200/JCO.2009.22.7041. Epub 2009 Nov 2. Review.

PMID:
19884547
6.

Early detection of second breast cancers improves prognosis in breast cancer survivors.

Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW.

Ann Oncol. 2009 Sep;20(9):1505-10. doi: 10.1093/annonc/mdp037. Epub 2009 Mar 17.

PMID:
19297316
7.

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.

Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, Pisano ED, Jong RA, Evans WP, Morton MJ, Mahoney MC, Larsen LH, Barr RG, Farria DM, Marques HS, Boparai K; ACRIN 6666 Investigators.

JAMA. 2008 May 14;299(18):2151-63. doi: 10.1001/jama.299.18.2151. Erratum in: JAMA. 2010 Apr 21;303(15):1482.

8.

Digital mammography: clinical implementation and clinical trials.

D'Orsi CJ, Newell MS.

Semin Roentgenol. 2007 Oct;42(4):236-42. Review. No abstract available.

PMID:
17919526
9.

Method of detection of new contralateral primary breast cancer in younger versus older women.

Robinson A, Speers C, Olivotto I, Chia S.

Clin Breast Cancer. 2007 Aug;7(9):705-9.

PMID:
17919351
10.

Triple-negative breast cancer: clinical features and patterns of recurrence.

Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34.

11.

MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.

Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD; ACRIN Trial 6667 Investigators Group.

N Engl J Med. 2007 Mar 29;356(13):1295-303. Epub 2007 Mar 28.

12.

Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.

Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1313-9. Epub 2006 Sep 25.

PMID:
16997501
13.

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.

Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R.

Ann Intern Med. 2003 Feb 4;138(3):168-75. Erratum in: Ann Intern Med. 2003 May 6;138(9):771.

PMID:
12558355
14.

What is achieved by mammographic surveillance after breast conservation treatment for breast cancer?

Ashkanani F, Sarkar T, Needham G, Coldwells A, Ah-See AK, Gilbert FJ, Hutcheon AW, Eremin O, Heys SD.

Am J Surg. 2001 Sep;182(3):207-10.

PMID:
11587678
15.

Value of contralateral surveillance mammography for primary breast cancer follow-up.

Kollias J, Evans AJ, Wilson AR, Ellis IO, Elston CW, Blamey RW.

World J Surg. 2000 Aug;24(8):983-7; discussion 988-9.

PMID:
10865045
16.

Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.

Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E.

J Natl Cancer Inst. 1999 Dec 1;91(23):2020-8.

PMID:
10580027
17.

Epidemiology of contralateral breast cancer.

Chen Y, Thompson W, Semenciw R, Mao Y.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):855-61. Review.

18.

Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer.

Joseph E, Hyacinthe M, Lyman GH, Busch C, Demps L, Reintgen DS, Cox CE.

Ann Surg Oncol. 1998 Sep;5(6):522-8.

PMID:
9754761
19.

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Chang-Claude J, Sobol H, Weber B, Stratton MR, Easton DF.

J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45.

PMID:
9701363
20.

Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.

Grosse A, Schreer I, Frischbier HJ, Maass H, Loening T, Bahnsen J.

Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):761-7.

PMID:
9240644

Supplemental Content

Support Center